Results 151 to 160 of about 254,699 (197)
Some of the next articles are maybe not open access.
Intravenous Immunoglobulins as Therapeutic Agents
Annals of Internal Medicine, 1987Intravenous immunoglobulins are stable monomeric pooled human IgG preparations for therapeutic use. Three intravenous immunoglobulins licensed in the United States are generally therapeutically equivalent. Intravenous immunoglobulin is the preferred agent for replacement therapy for most patients with primary or secondary antibody immunodeficiency ...
E R, Stiehm +5 more
openaire +2 more sources
Clinical Use of Intravenous Immunoglobulins
Vox Sanguinis, 2000Prophylaxis and treatment with i.v. immunoglobulins must envisage preparations from normal or hyperimmunised human donors, animals (horses and rabbits) as well as monoclonal and genetically and proteomically engineered chimeric or recombinant antibodies.
U E, Nydegger +3 more
openaire +2 more sources
Human intravenous immunoglobulin therapy
Seminars in Veterinary Medicine and Surgery: Small Animal, 1997Human intravenous immunoglobulin (hIVIG) is a preparation of normal polyspecific IgG obtained from the plasma of healthy blood donors. Although purified immunoglobulins were initially developed for treatment of primary immunodeficiency syndromes, they have since been documented to be effective in the treatment of some immune-mediated diseases such as ...
J. Catharine +2 more
openaire +2 more sources
INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS
The Lancet, 1983P, Stanley, P, Cole
openaire +4 more sources
Sepsis and polyspecific intravenous immunoglobulins
Journal of Clinical Apheresis, 1997The treatment of sepsis with i.v. immunoglobulins (IVIG) is currently regarded as not indicated. Several clinical studies, placebo controlled since 1985, to determine efficacy have failed to prevent fatal outcome, even when IVIG was given at high doses.
openaire +3 more sources
SAFETY OF INTRAVENOUS IMMUNOGLOBULIN
The Lancet, 1987W L, Shaw, R R, Stewart
openaire +2 more sources
Consensus statement. National Institutes of Health Consensus Development Conference, 1991
The National Institutes of Health Consensus Development Conference on Intravenous Immunoglobulin: Prevention and Treatment of Disease brought together biomedical scientists in immunology, infectious disease, and pediatrics, as well as health care providers, patients and their families, and the public to address the safe and effective uses of ...
openaire +1 more source
The National Institutes of Health Consensus Development Conference on Intravenous Immunoglobulin: Prevention and Treatment of Disease brought together biomedical scientists in immunology, infectious disease, and pediatrics, as well as health care providers, patients and their families, and the public to address the safe and effective uses of ...
openaire +1 more source